A Phase 2 Study of AZD0530 in Recurrent or Metastatic Soft Tissue Sarcoma.

Trial Profile

A Phase 2 Study of AZD0530 in Recurrent or Metastatic Soft Tissue Sarcoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2015

At a glance

  • Drugs Saracatinib (Primary)
  • Indications Dermatofibrosarcoma; Leiomyosarcoma; Liposarcoma; Rhabdomyosarcoma; Soft tissue sarcoma; Uterine leiomyoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 06 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top